ISFMS 2025 Abstract Submission - Final Day

投放时间: 2025-06-20 08:00:00
🚨𝐅𝐢𝐧𝐚𝐥 𝐃𝐚𝐲 𝐭𝐨 𝐒𝐮𝐛𝐦𝐢𝐭 𝐲𝐨𝐮𝐫 𝐀𝐛𝐬𝐭𝐫𝐚𝐜𝐭𝐬 𝐟𝐨𝐫 𝐈𝐒𝐅𝐌𝐒 𝟐𝟎𝟐𝟓! 𝐓𝐡𝐞 𝐚𝐛𝐬𝐭𝐫𝐚𝐜𝐭 𝐬𝐮𝐛𝐦𝐢𝐬𝐬𝐢𝐨𝐧 𝐝𝐞𝐚𝐝𝐥𝐢𝐧𝐞 𝐜𝐥𝐨𝐬𝐞𝐬 𝐨𝐧 𝟏𝟓 𝐌𝐚𝐲 𝟐𝟎𝟐𝟓. This is the final chance to submit your abstracts to ISFMS 2025! Authors with outstanding submissions will stand a chance to receive attractive conference awards. Don’t Miss This Opportunity! Each Best Oral Presentation Award and Best Poster Presentation Award winner will be entitled to one publication in the IJMS journal, with the Article Processing Charges (APC) of 2,900CHF waived. 💡𝐒𝐞𝐬𝐬𝐢𝐨𝐧𝐬 𝐚𝐭 𝐈𝐒𝐅𝐌𝐒 𝟐𝟎𝟐𝟓 S1. Protein Structure and Molecular Dynamics S2. Enzymes S3. Membrane Proteins S4. Cancer Target Proteins S5. Drug Design and Solution to Drug Resistance Problem S6. Physiological Functions of Proteins and Organ Interactions 🔗For the updated list of event and session chairs at ISFMS 2025, please visit our website: https://brnw.ch/21wSHBd 🔗To submit your abstract, please click on the following link: https://brnw.ch/21wSHBi 🔗To register, please click here: https://brnw.ch/21wSHBl 📅Important Dates ⭕New Abstract Submission Deadline: 1̵5̵ ̵A̵p̵r̵i̵l̵ ̵2̵0̵2̵5̵ 15 May 2025 ⭕New Early Bird Registration Deadline: ̵1̵5̵ ̵J̵u̵n̵e̵ ̵2̵0̵2̵5̵ 15 July 2025 ⭕Registration Deadline: 26 August 2025 #ISFMS2025 #Conferences #Preteins #Presentation
搜索关键词 ISFMS 2025 conference, protein structure, drug design conference, molecular dynamics, abstract submission, conference awards, IJMS publication, scientific conference, research presentation, proteins conference优势 Opportunity to present research,Chance to win awards,Publication opportunity in IJMS with waived APC for award winners,Networking with experts
展示估值
155036
热度
13149
最新发现时间
2025-06-20 08:00:00
投放天数
210

平台 & 渠道

投放渠道 facebook
系统 pc
国家 瑞士
语言 英语

素材信息

素材类型
素材尺寸
主页ID8289873642116187572
主页名字International Journal of Molecular Sciences

适用范围

适用人群both
劣势Limited time to submit,Conference fee likely applies
情感Stimulation
人民币汇率走势
CNY
亚马逊热销榜
共 0 SKU 上次更新 NaN:NaN:NaN
类目: 切换分类
暂无数据
暂无数据
关注我们
NMedia
新媒网跨境发布
本站原创内容版权归作者及NMedia共同所有,未经许可,禁止以任何形式转载。